Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 3/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.78 |
| ▸ | SQLE | Q14534 | 5/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.57 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.57 |
| ▸ | ICMT | O60725 | 1/20 | 0.50 |
| ▸ | FNTA | P49354 | 1/20 | 0.47 |
| ▸ | FNTB | P49356 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7935256 | 1.00 | ALOX15 (0.78) | ALOX15ALDH1A1SQLEKMT2AMAPT | |
| SCHEMBL1301278 | 1.00 | ALOX15 (0.78) | ALOX15ALDH1A1SQLEKMT2AMAPT | |
| SCHEMBL7944396 | 1.00 | ALOX15 (0.78) | ALOX15ALDH1A1SQLEKMT2AMAPT | |
| SCHEMBL7935259 | 1.00 | ALOX15 (0.78) | ALOX15ALDH1A1SQLEKMT2AMAPT | |
| SCHEMBL7942977 | 1.00 | ALOX15 (0.78) | ALOX15ALDH1A1SQLEKMT2AMAPT | |
| SCHEMBL7785624 | 1.00 | ALOX15 (0.78) | ALOX15ALDH1A1SQLEKMT2AMAPT | |
| SCHEMBL7934879 | 1.00 | ALOX15 (0.78) | ALOX15ALDH1A1SQLEKMT2AMAPT | |
| SCHEMBL7944394 | 1.00 | ALOX15 (0.78) | ALOX15ALDH1A1SQLEKMT2AMAPT | |
| SCHEMBL15506005 | 1.00 | ALOX15 (0.78) | ALOX15ALDH1A1SQLEKMT2AMAPT | |
| SCHEMBL7942976 | 1.00 | ALOX15 (0.78) | ALOX15ALDH1A1SQLEKMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12540110-B2 | Dihydroxylation of olefins using osmate (VI) salts | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2026-02-03 | — | — | US | claimed |
| WO-2025068206-A1 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2025-04-03 | — | — | WO | claimed |
| US-20220388931-A1 | DIHYDROXYLATION OF OLEFINS USING OSMATE (VI) SALTS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2022-12-08 | — | — | US | claimed |
| EP-4054995-A1 | DIHYDROXYLATION OF OLEFINS USING OSMATE (VI) SALTS | International Flavors & Fragrances Inc. (US) | 2022-09-14 | — | — | EP | claimed |
| EP-3826986-B1 | NOVEL ODORANTS HAVING ROSE ODOUR | SYMRISE AG (DE) | 2026-03-04 | — | — | EP | disclosed |
| WO-2025125532-A1 | PERFUME INGREDIENTS AND COMPOSITIONS CONTAINING THEM | GIVAUDAN SA (CH) | 2025-06-19 | — | — | WO | disclosed |
| WO-2025068206-A1 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2025-04-03 | — | — | WO | disclosed |
| WO-2023213310-A9 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | 太阳雨林(北京)生物医药有限公司 | 2025-02-20 | — | — | WO | disclosed |
| CN-118984866-A | Agave spirit replica | 艾娃食品实验室股份有限公司 | 2024-11-19 | — | — | CN | disclosed |
| US-20240277012-A1 | DUPLICATE BEVERAGE | WANG JIE (US) | 2024-08-22 | — | — | US | disclosed |
| CN-118355100-A | Packaging containing water-soluble capsules | 联合利华知识产权控股有限公司 | 2024-07-16 | — | — | CN | disclosed |
| US-20240108040-A1 | HIGH INTENSITY SWEETENERS | FIRMENICH INCORPORATED (US) | 2024-04-04 | — | — | US | disclosed |
| US-5212164-A | Hypocholesterolemic and antiatherosclerotic agents | E. R. SQUIBB & SONS, INC. (US) | 1993-05-18 | — | — | US | disclosed |
| US-4962242-A | HYDROGENATING OLEFINIC ALCOHOL USING AS CATALYST A RUTHENIUM-OPTICALLY ACTIVE PHOSPHINE COMPLEX | TAKASAGO PERFUMERY CO., LTD. (JP) | 1990-10-09 | — | — | US | disclosed |
| EP-0258967-A2 | Process for producing optically active alcohols | Takasago Perfumery Co., Ltd. (JP) | 1988-03-09 | — | — | EP | disclosed |
| US-4624966-A | β,γ-dihydropolyprenyl alcohol derivatives and pharmaceutical composition containing a polyprenyl compound | EISAI CO., LTD. (JP) | 1986-11-25 | — | — | US | disclosed |
| US-4571408-A | α,β-Dihydropolyprenyl derivatives for treating hepatitis | EISAI CO., LTD. (JP) | 1986-02-18 | — | — | US | disclosed |
| EP-0041235-B1 | ALPHA,BETA-DIHYDROPOLYPRENYL DERIVATIVES FOR TREATING LIVER DISEASES | Eisai Co., Ltd. (JP) | 1985-02-13 | — | — | EP | disclosed |
| US-4481217-A | TERPENE ALCOHOLS, ACIDS OR ESTERS | EISAI CO., LTD. (JP) | 1984-11-06 | — | — | US | disclosed |
| EP-0098620-A2 | Alpha,beta-dihydropolyprenyl derivatives and a process for preparing these derivatives | Eisai Co., Ltd. (JP) | 1984-01-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240108040-A1 | HIGH INTENSITY SWEETENERS | TAS2R40, TAS2R60, TAS1R1 | ALOX15 3088/4885ALDH1A1 978/4885SQLE 2303/4885 |
| US-12540110-B2 | Dihydroxylation of olefins using osmate (VI) salts | MSMO1, ADH5, ADH1C | ALOX15 340/4885ALDH1A1 238/4885SQLE 17/4885 |
| US-20220388931-A1 | DIHYDROXYLATION OF OLEFINS USING OSMATE (VI) SALTS | DRD3, DHODH, EBP | ALOX15 2075/4885ALDH1A1 360/4885SQLE 515/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.